SPRR2A anticorps (C-Term)

N° du produit ABIN954943

Détail du produit anti-SPRR2A anticorps

Antigène: SPRR2A (Small Proline Rich Protein 2A (SPRR2A))

Épitope: AA 51-76, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SPRR2A est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody recognizes SPRR2A at C-term.

Réactivité croisée (Details): Species reactivity (tested):Human

Purification: Purified through a Protein A column followed by peptide affinity purification

Immunogène: Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 51-76aa) of human SPRR2A

Isotype: Ig Fraction

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) Sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur SPRR2A

Antigène: SPRR2A (Small Proline Rich Protein 2A (SPRR2A))

Autre désignation: SPRR2A (SPRR2A Produits)

Synonymes: anticorps SPRR2A, anticorps Sprr2a, anticorps small proline-rich protein 2A, anticorps small proline rich protein 2A, anticorps small proline-rich protein 2A1, anticorps SPRR2A, anticorps Sprr2a1

Sujet: The SPRR2A gene encodes a cross-linked envelope protein of keratinocytes. It is a keratinocyte protein that first appears in the cell cytosol, but ultimately becomes cross-linked to membrane proteins by transglutaminase. All that results in the formation of an insoluble envelope beneath the plasma membrane.Synonyms: SPR-2A, Small proline-rich protein 2A

ID gène: 6700

NCBI Accession: NP_005979